Family-based association study between SLC2A1, HK1, and LEPR polymorphisms with myelomeningocele in Chile

Reproductive Sciences

Volumn 20, Issue 10, 2013, Pages 1207-1214

  Suazo, José ^a   Pardo, Rosa ^b,c   Castillo, Silvia ^b,d   Martin, Luz Maria ^b   Rojas, Francisca ^b   Santos, José Luis ^a   Rotter, Karin ^e   Solar, Margarita ^e   Tapia, Eva ^f  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^c HOSPITAL DR SÓTERO DEL RÍO   (Chile)

^d UNIVERSIDAD DEL DESARROLLO   (Chile)

^e Sociedad Pro Ayuda Del Niño Lisiado ^*  (Chile)

^f Centro de Rehabilitación Infantil Del Ejército   (Chile)

Author keywords

energy homeostasis; HK1; LEPR; myelomeningocele; SLC2A1

Indexed keywords

GLUCOSE TRANSPORTER 1; HEXOKINASE 1; LEPTIN RECEPTOR;

ALLELE; ARTICLE; BIRTH DEFECT; CHILD; CHILE; FAMILY STUDY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MENINGOMYELOCELE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ENERGY HOMEOSTASIS; HK1; LEPR; MYELOMENINGOCELE; SLC2A1;

ALLELES; CHILD; CHILD, PRESCHOOL; CHILE; FEMALE; GENETIC ASSOCIATION STUDIES; GLUCOSE TRANSPORTER TYPE 1; HEXOKINASE; HUMANS; INFANT; MALE; MENINGOMYELOCELE; PARENTS; POLYMORPHISM, GENETIC; RECEPTORS, LEPTIN;

EID: 84883718766     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719113477489     Document Type: Article

References (69)

1. Bassuk AG, Kibar Z. Genetic basis of neural tube defects. Semin Pediatr Neurol. 2009 ; 16 (3). 101-110
2. Gutierrez FR, Woodard PK, Fleishman MJ Diagnostic Neuroradiology. Osborn AG Maack H, ed. St. Louis, MO: Mosby ; 1994: 785-819.
3. Melvin EC, George TM, Worley G, et al. Genetic studies in neural tube defects. NTD Collaborative Group. Pediatr Neurosurg. 2000 ; 32 (1). 1-9
4. Tortori-Donati P, Rossi A, Cama A. Spinal dysraphism: a review of neuroradiological features with embryological correlations and proposal for a new classification. Neuroradiology. 2000 ; 42 (7). 471-491
5. Cortés F, Mellado C, Pardo RA, Villarroel LA, Hertrampf E. Wheat flour fortification with folic acid: changes in neural tube defects rates in Chile. Am J Med Genet A. 2012 ; 158A (8). 1885-1890
6. López-Camelo JS, Castilla EE, Orioli IM. Folic acid flour fortification: impact on the frequencies of 52 congenital anomaly types in three South American countries. Am J Med Genet A. 2010 ; 152A (10). 2444-2458
7. Botto LD, Moore CA, Khoury MJ, Erickson JD. Neural-tube defects. N Engl J Med. 1999 ; 341 (20). 1509-1519
8. Au KS, Ashley-Koch A, Northrup H. Epidemiologic and genetic aspects of spina bifida and other neural tube defects. Dev Disabil Res Rev. 2010 ; 16 (1). 6-15
9. Harris MJ, Juriloff DM. Mouse mutants with neural tube closure defects and their role in understanding human neural tube defects. Birth Defects Res A Clin Mol Teratol. 2007 ; 79 (3). 187-210
10. Green R.. Is it time for vitamin B-12 fortification? What are the questions?. Am J Clin Nutr. 2009 ; 89 (2). 712S - 716S
11. Racusin D, Stevens B, Campbell G, Aagaard KM. Obesity and the risk and detection of fetal malformations. Semin Perinatol. 2012 ; 36 (3). 213-221
12. Carmichael SL, Rasmussen SA, Shaw GM. Prepregnancy obesity: a complex risk factor for selected birth defects. Birth Defects Res A Clin Mol Teratol. 2010 ; 88 (10). 804-810
13. Moley KH, Chi MM, Knudson CM, Korsmeyer SJ, Mueckler MM. Hyperglycemia induces apoptosis in preimplantation embryos through cell death effector pathways. Nature Med. 1998 ; 4 (12). 1421-1424
14. Chang TI, Loeken MR. Genotoxicity and diabetic embryopathy: impaired expression of developmental control genes as a cause of defective morphogenesis. Semin Repord Endocrinol. 1999 ; 17 (2). 153-165
15. Moley KH. Hyperglycemia and apoptosis: mechanisms for congenital malformations and pregnancy loss in diabetic women. Trends Endocrinol Metab. 2001 ; 12 (2). 78-82
16. Fine EL, Horal M, Chang TI, Fortin G, Loeken MR. Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy. Diabetes. 1999 ; 48 (812). 2454-2462
17. Fu J, Tay SS, Ling EA, Dheen ST. High glucose alters the expression of genes involved in proliferation and cell-fate specification of embryonic neural stem cells. Diabetologia. 2006 ; 49 (5). 1027-1038
18. Phelan SA, Ito M, Loeken MR. Neural tube defects in embryos of diabetic mice: role of the Pax-3 gene and apoptosis. Diabetes. 1997 ; 46 (7). 1189-1197
19. Yazdy MM, Liu S, Mitchell AA, Werler MM. Maternal dietary glycemic intake and the risk of neural tube defects. Am J Epidemiol. 2010 ; 171 (4). 407-414
20. Davidson CM, Northrup H, King TM, et al. Genes in glucose metabolism and association with spina bifida. Reprod Sci. 2008 ; 15 (1). 51-58
21. Carter TC, Pangilinan F, Troendle JF, et al. Evaluation of 64 candidate single nucleotide polymorphisms as risk factors for neural tube defects in a large Irish study population. Am J Med Genet A. 2011 ; 155A (1). 14-21
22. Guilmatre A, Sharp AJ. Parent of origin effects. Clin Genet. 2012 ; 81 (3). 201-209
23. Weinberg CR. Methods for detection of parent-of-origin effects in genetic studies of case-parents triads. Am J Hum Genet. 1999 ; 65 (1). 229-235
24. Hager R, Cheverud JM, Wolf JB. Maternal effects as the cause of parent-of-origin effects that mimic genomic imprinting. Genetics. 2008 ; 178 (3). 1755-1762
25. Wilkins JF, Haig D. What good is genomic imprinting: the function of parent-specific gene expression. Nat Rev Genet. 2003 ; 4 (5). 359-368
26. Christensen B, Arbour L, Tran P, et al. Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet. 1999 ; 84 (2). 151-157
27. Dean JC, Moore SJ, Osborne A, Howe J, Turnpenny PD. Fetal anticonvulsant syndrome and mutation in the maternal MTHFR gene. Clin Genet. 1999 ; 56 (3). 216-220
28. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 ; 162 (1). 156-159
29. Hodgkinson AD, Page T, Millward BA, Demaine AG. A novel polymorphism in the 5' flanking region of the glucose transporter (GLUT1) gene is strongly associated with diabetic nephropathy in patients with Type 1 diabetes mellitus. J Diabetes Complications. 2005 ; 19 (2). 65-69
30. Soranzo N, Sanna S, Wheeler E, et al. Common variants at 10 genomic loci influence hemoglobin A1(C) levels via glycemic and nonglycemic pathways. Diabetes. 2010 ; 59 (12). 3229-3239
31. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet. 1993 ; 52 (3). 506-516
32. Dudbridge F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered. 2008 ; 66 (2). 87-98
33. Cordell HJ, Barratt BJ, Clayton DG. Case/pseudocontrol analysis in genetic association studies: a unified framework for detection of genotype and haplotype associations, gene-gene and gene-environment interactions, and parent-of-origin effects. Genet Epidemiol. 2004 ; 26 (3). 167-185
34. Bland JM, Altman DG. Statistics notes. The odds ratio. BMJ. 2000 ; 320 (7247). 1468
35. Guo X, Geng M, Du G. Glucose transporter 1, distribution in the brain and in neural disorders: its relationship with transport of neuroactive drugs through the blood-brain barrier. Biochem Genet. 2005 ; 43 (3-4). 175-187
36. Trocino R, Akazawa S, Takino H, et al. Cellular-tissue localization and regulation of the GLUT-1 protein in both the embryo and the visceral yolk sac from normal and experimental diabetic rats during the early postimplantation period. Endocrinology. 1994 ; 134 (2). 869-878
37. Gao L, Lv C, Xu C, et al. Differential regulation of glucose transporters mediated by CRH receptor type 1 and type 2 in human placental trophoblasts. Endocrinology. 2012 ; 153 (3). 1464-1471
38. Morita Y, Tsutsumi O, Oka Y, Taketani Y. Glucose transporter GLUT1 mRNA expression in the ontogeny of glucose incorporation in Mouse preimplantation embryos. Biochem Biophys Res Commun. 1994 ; 199 (3). 1525-1531
39. Matsumoto K, Akazawa S, Ishibashi M, et al. Abundant expression of GLUT1 and GLUT3 in rat embryo during the early organogenesis period. Biochem Biophys Res Commun. 1995 ; 209 (1). 95-102
40. Chi MM, Pingsterhaus J, Carayannopoulos M, Moley KH. Decreased glucose transporter expression triggers BAX-dependent apoptosis in the murine blastocyst. J Biol Chem. 2000 ; 275 (51). 40252-40257
41. Heilig CW, Saunders T, Brosius FC, et al. Glucose transporter-1-deficient mice exhibit impaired development and deformities that are similar to diabetic embryopathy. Proc Natl Acad Sci U S A. 2003 ; 100 (26). 15613-15618
42. Illsley NP. Glucose transporters in the human placenta. Placenta. 2000 ; 21 (1). 14-22
43. Bianchi M, Magnani M. Hexokinase mutations that produce nonspherocytic hemolytic anemia. Blood Cells Mol Dis. 1995 ; 21 (1). 2-8
44. Farooqi IS, O'Rahilly S. Mutations in ligands and receptors of the leptin-melanocortin pathway that lead to obesity. Nat Clin Pract Endocrinol Metab. 2008 ; 4 (10). 569-577
45. Mansour E, Pereira FG, Araújo EP, et al. Leptin inhibits apoptosis in thymus through a janus kinase-2-independent, insulin receptor substrate-1/phosphatidylinositol-3 kinase-dependent pathway. Endocrinology. 2006 ; 147 (11). 5470-5479
46. Zhang Y, Huang C. Targeting adipocyte apoptosis: a novel strategy for obesity therapy. Biochem Biophys Res Commun. 2012 ; 417 (1). 1-4
47. Beaty TH, Hetmanski JB, Zeiger JS, et al. Testing candidate genes for non-syndromic oral clefts using a case-parent trio design. Genet Epidemiol. 2002 ; 22 (1). 1-11
48. Valenzuela CY, Acuña MP, Harb Z. Sociogenetic gradient in the Chilean population. Rev Med Chil. 1987 ; 115 (4). 295-299
49. Valenzuela CY. On sociogenetic clines. Ethol Sociobiol. 1988 ; 9 (5). 259-268
50. Suazo J, Santos JL, Carreño H, Jara L, Blanco R. Linkage disequilibrium between MSX1 and non-syndromic cleft lip/palate in the Chilean population. J Dent Res. 2004 ; 83 (10). 782-725
51. Toriello HV, Higgins JV. Possible causal heterogeneity in spina bifida cystica. Am J Med Genet. 1985 ; 21 (1). 13-20
52. Toriello HV, Higgins JV. Occurrence of neural tube defects among first-, second-, and third-degree relatives of probands: results of a United States study. Am J Med Genet. 1983 ; 15 (4). 601-606
53. Hall J, Solehdin F. Folic acid for the prevention of congenital anomalies. Eur J Pediatr. 1998 ; 157 (6). 445-450
54. Drainer E, May HM, Tolmie JL. Do familial neural tube defects breed true?. J Med Genet. 1991 ; 28 (9). 605-608
55. Garabedian BH, Fraser FC. Upper and lower neural tube defects: an alternate hypothesis. J Med Genet. 1993 ; 30 (10). 849-851
56. Källén B, Cocchi G, Knudsen LB, et al. International study of sex ratio and twinning of neural tube defects. Teratology. 1994 ; 50 (5). 322-331
57. Seller MJ. Sex, neural tube defects, and multisite closure of the human neural tube. Am J Med Genet. 1995 ; 58 (4). 332-336
58. Dolk H, De Wals P, Gillerot Y, et al. Heterogeneity of neural tube defects in Europe: the significance of site of defect and presence of other major anomalies in relation to geographic differences in prevalence. Teratology. 1991 ; 44 (5). 547-559
59. Robert E, Guibaud P. Maternal valproic acid and congenital neural tube defects. Lancet. 1982 ; 2 (8304). 937
60. Van Allen MI, Kalousek DK, Chernoff GF, et al. Evidence for multi-site closure of the neural tube in humans. Am J Med Genet. 1993 ; 47 (5). 723-743
61. Lindhout D, Omtzigt JG, Cornel MC. Spectrum of neural-tube defects in 34 infants prenatally exposed to antiepileptic drugs. Neurology. 1992 ; 42 (4 suppl 5). 111-118
62. Escamilla MA, McInnes LA, Spesny M, et al. Assessing the feasibility of linkage disequilibrium methods for mapping complex traits: an initial screen for bipolar disorder loci on chromosome 18. Am J Hum Genet. 1999 ; 64 (6). 1670-1678
63. Martin ER, Lai EH, Gilbert JR, et al. SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. Am J Hum Genet. 2000 ; 67 (2). 383-394
64. Akey J, Jin L, Xiong M. Haplotypes vs single marker linkage disequilibrium tests: what do we gain?. Eur J Hum Genet. 2001 ; 9 (4). 291-300
65. Schork NJ. Genetics of complex disease: approaches, problems, and solutions. Am J Respir Crit Care Med. 1997 ; 156 (4 pt 2). S103 - S109
66. Barroso I, Luan J, Middelberg RP, et al. Candidate gene association study in type 2 diabetes indicates a role for genes involved in b-cell function as well as insulin action. PLoS Biol. 2003 ; 1 (1). 41-45
67. Perneger TV. Adjusting for multiple testing in studies is less important than other concerns. Brit Med J. 1999 ; 318 (7193). 1288
68. Hiekkalinna T, Göring HH, Lambert B, et al. On the statistical properties of family-based association tests in datasets containing both pedigrees and unrelated case-control samples. Eur J Hum Genet. 2012 ; 20 (2). 217-223
69. Laird NM, Horvath S, Xu X. Implementing a unified approach to family-based tests of association. Genet Epidemiol. 2000 ; 19 (suppl 1). S36 - S42